Different-sized incisions for phacoemulsification in age-related cataract
Chongfei Jin1, Xinyi Chen, Andrew Law
1Eye Center of the Second Affiliated Hospital, Medical College of Zhejiang University, 88 Jiefang Road, Hangzhou, China, 310009.
The Cochrane Database of Systematic Reviews
|September 21, 2017
Summary
Phacoemulsification using smaller incisions for age-related cataract surgery did not consistently reduce surgically induced astigmatism. While microincision techniques may offer a slight benefit, evidence on safety and quality of life remains uncertain.
Area of Science:
- Ophthalmology
- Surgical Innovation
- Evidence-Based Medicine
Background:
- Age-related cataract is a leading cause of global vision impairment.
- Phacoemulsification is the standard surgical treatment for cataracts.
- The impact of incision size on phacoemulsification outcomes requires clarification.
Purpose of the Study:
- To systematically review the effectiveness and safety of smaller versus larger incisions in phacoemulsification for age-related cataracts.
- To assess surgically induced astigmatism as the primary outcome at three months post-surgery.
Main Methods:
- Conducted a systematic review of randomized controlled trials (RCTs).
- Searched multiple databases including CENTRAL, MEDLINE, Embase, PubMed, and LILACS without date or language restrictions.
- Included 26 RCTs involving 2737 participants comparing incision sizes from <= 1.5 mm to approximately 3.0 mm.
Main Results:
- Coaxial microincision phacoemulsification (C-MICS) showed a small, uncertain reduction in astigmatism compared to standard phacoemulsification.
- No consistent association found between smaller incisions and reduced surgically induced astigmatism.
- Evidence on visual acuity, endothelial cell loss, and corneal thickness showed little to no significant differences between most incision sizes.
Conclusions:
- Smaller incisions in phacoemulsification do not consistently reduce surgically induced astigmatism.
- The potential benefits of microincision techniques require further investigation due to uncertain evidence.
- Future research should prioritize reporting on safety outcomes and patient quality of life.
Related Concept Videos
Angle Closure Glaucoma: Treatment
1.4K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.4K
Open Angle Glaucoma: Treatment
1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Glaucoma: Overview
1.5K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.5K


